Also part of the UPMC family:
Catalin Toma, MD, is leading a phase II multicenter clinical trial. The study will assess the safety of AMI MultiStem® in people after a recent heart attack.
AMI MultiStem vial is a cell therapy product made from adult stem cells found in bone marrow. Researchers take the stem cells from a non-related donor and expand them ex-vivo.
Trial subjects will receive MultiStem via catheter into the outer layer of the target vein after successful angioplasty.
McGowan Institute for Regenerative Medicine
450 Technology Drive
Suite 300
Pittsburgh, PA 15219
Read information on campus shuttles.
Phone: 412-624-5500
Fax: 412-624-5363
Email: McGowan@pitt.edu
